Resona Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Resona Asset Management's LLY Position: Q1 2026 in Review
Resona Asset Management increased its Eli Lilly (LLY) stake by 2% in Q1 2026, buying an estimated $5.22M and bringing the position to 258,768 shares worth $236M. The position accounts for 1.18% of the portfolio, ranked #12.
Resona Asset Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $273M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Resona Asset Management held 258,768 shares of Eli Lilly worth $236M as of Q1 2026.
- Resona Asset Management bought 5,144 Eli Lilly shares in Q1 2026, an estimated $5.22M.
- Eli Lilly made up 1.18% of Resona Asset Management's portfolio in Q1 2026, its #12 holding.
- Resona Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- Resona Asset Management's Eli Lilly position peaked at $273M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Resona Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.